MKI67 and hepatocellular carcinoma: Previous studies showed that expression of Ki-67 is valuable in selecting recipients for liver transplant [2], patients with high Ki-67 expression are often encouraged to receive preoperative adjuvant therapy to improve prognosis [3], and Ki-67-targeted therapy is an attractive and promising avenue in HCC treatment [4].